Kalaris Therapeutics (KLRS) Selling, General & Administrative (2019 - 2026)
Kalaris Therapeutics' Selling, General & Administrative came in at $3.37 million for Q2 2026, down 11.7% from $3.82 million a year earlier and down 21.0% from the prior quarter.
Powered by 
Analysis
Kalaris Therapeutics (KLRS) Selling, General & Administrative (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Kalaris Therapeutics reported Selling, General & Administrative of $14.89 million, up 12.3% year-over-year; for FY2025, it came in at $15.4 million, up 130.2% from FY2024.
- Selling, General & Administrative carries a five-year compound annual growth rate of -6.6% (FY2020 to FY2025).
- Going back by year, Selling, General & Administrative was $6.69 million in FY2024 (-86.1%), $48.26 million in FY2023 (-7.8%), $52.33 million in FY2022 (+6.6%) and $49.08 million in FY2021 (+126.8%).
- The Q2 2026 figure represents the lowest quarterly Selling, General & Administrative since Q4 2024.
- Year-over-year, Selling, General & Administrative increased in four of the last eight quarters, with growth averaging 106.3%.
- The fastest year-over-year change in Selling, General & Administrative over five years came in Q1 2025 (growth of 618.3%), and the weakest in Q1 2024 (a decline of 95.2%).
- Business Quant data shows KLRS's Selling, General & Administrative at $4.26 million (Q1 2026), $3.64 million (Q4 2025) and $3.62 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Kalaris Therapeutics | 64.27 Mn | 64.27 Mn | - | 3.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.37 Mn |
| Mar 31, 2026 | 4.26 Mn |
| Dec 31, 2025 | 3.64 Mn |
| Sep 30, 2025 | 3.62 Mn |
| Jun 30, 2025 | 3.82 Mn |
| Mar 31, 2025 | 4.32 Mn |
| Dec 31, 2024 | 3.28 Mn |
| Sep 30, 2024 | 1.83 Mn |
| Jun 30, 2024 | 976,000.00 |
| Mar 31, 2024 | 602,000.00 |
| Dec 31, 2023 | 10.46 Mn |
| Sep 30, 2023 | 12.81 Mn |
| Jun 30, 2023 | 12.48 Mn |
| Mar 31, 2023 | 12.51 Mn |
| Dec 31, 2022 | 12.01 Mn |
| Sep 30, 2022 | 12.95 Mn |
| Jun 30, 2022 | 13.25 Mn |
| Mar 31, 2022 | 14.13 Mn |
| Dec 31, 2021 | 14.19 Mn |
| Sep 30, 2021 | 12.44 Mn |
API Access
Kalaris Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=KLRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "KLRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=KLRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();